Headlines

Headlines: Coronavirus Claims One More Life In India, Total Death Toll At 3

The first human trial to evaluate a candidate vaccine against the new coronavirus has begun in Seattle, US health officials said Monday, raising hopes in the global fight against the disease. But it may be another year to 18 months before it becomes available, once it has passed more trial phases to prove it works and is safe. The vaccine is called mRNA-1273 and was developed by US National Institutes of Health (NIH) scientists and collaborators at biotechnology company Moderna, which is based in Cambridge, Massachusetts.
#COVID19 #CoronavirusInIndia #RanjanGogoi

Dear Readers,
As an independent media platform, we do not take advertisements from governments and corporate houses. It is you, our readers, who have supported us on our journey to do honest and unbiased journalism. Please contribute, so that we can continue to do the same in future.

Related posts